• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于荚膜多糖的基因组特征、血清型、免疫原性及疫苗开发的叙述性综述

A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of capsular polysaccharide.

作者信息

Sari Ratna Fathma, Fadilah Fadilah, Maladan Yustinus, Sarassari Rosantia, Safari Dodi

机构信息

Master's Programme in Biomedical Sciences, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.

Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia.

出版信息

Clin Exp Vaccine Res. 2024 Apr;13(2):91-104. doi: 10.7774/cevr.2024.13.2.91. Epub 2024 Apr 30.

DOI:10.7774/cevr.2024.13.2.91
PMID:38752009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11091432/
Abstract

This narrative review describes genomic characteristic, serotyping, immunogenicity, and vaccine development of capsular polysaccharide (CPS). CPS is a primary virulence factor of . The genomic characteristics of CPS, including the role of biosynthetic gene and genetic variation within (capsule polysaccharide) locus which may lead to serotype replacement are still being investigated. One hundred unique serotypes of have been identified through various methods of serotyping using phenotypic and genotypic approach. The advantages and limitations of each method are various, emphasizing the need for accurate and comprehensive serotyping for effective disease surveillance and vaccine targeting. In addition, we elaborate the critical role of CPS in vaccine development by providing an overview of immunogenicity, ongoing research of pneumococcal vaccines, and the impact on disease burden.

摘要

本叙述性综述描述了荚膜多糖(CPS)的基因组特征、血清分型、免疫原性和疫苗开发。CPS是……的主要毒力因子。CPS的基因组特征,包括生物合成基因的作用以及(荚膜多糖)位点内可能导致血清型替换的基因变异仍在研究中。通过使用表型和基因型方法的各种血清分型方法,已鉴定出……的100种独特血清型。每种方法的优缺点各不相同,强调了为有效疾病监测和疫苗靶向进行准确和全面血清分型的必要性。此外,我们通过概述免疫原性、肺炎球菌疫苗的正在进行的研究以及对疾病负担的影响,阐述了CPS在疫苗开发中的关键作用。

相似文献

1
A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of capsular polysaccharide.关于荚膜多糖的基因组特征、血清型、免疫原性及疫苗开发的叙述性综述
Clin Exp Vaccine Res. 2024 Apr;13(2):91-104. doi: 10.7774/cevr.2024.13.2.91. Epub 2024 Apr 30.
2
A novel genetic variant of Streptococcus pneumoniae serotype 11A discovered in Fiji.在斐济发现的肺炎链球菌 11A 血清型的一种新型遗传变异。
Clin Microbiol Infect. 2018 Apr;24(4):428.e1-428.e7. doi: 10.1016/j.cmi.2017.06.031. Epub 2017 Jul 20.
3
Variants of Streptococcus pneumoniae Serotype 14 from Papua New Guinea with the Potential to Be Mistyped and Escape Vaccine-Induced Protection.巴布亚新几内亚 14 型肺炎链球菌血清型变体,具有潜在的误分型和逃避疫苗诱导保护的能力。
Microbiol Spectr. 2022 Aug 31;10(4):e0152422. doi: 10.1128/spectrum.01524-22. Epub 2022 Jul 12.
4
Construction of otherwise isogenic serotype 6B, 7F, 14, and 19F capsular variants of Streptococcus pneumoniae strain TIGR4.肺炎链球菌TIGR4菌株6B、7F、14和19F血清型同基因荚膜变异株的构建。
Appl Environ Microbiol. 2003 Dec;69(12):7364-70. doi: 10.1128/AEM.69.12.7364-7370.2003.
5
A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large Fragment from an Oral Streptococcus.一种新型肺炎球菌荚膜类型 10D 是第 100 种血清型,具有来自口腔链球菌的大片段。
mBio. 2020 May 19;11(3):e00937-20. doi: 10.1128/mBio.00937-20.
6
Identification and genetic engineering of pneumococcal capsule-like polysaccharides in commensal oral streptococci.鉴定和遗传工程在共生口腔链球菌中的肺炎球菌荚膜样多糖。
Microbiol Spectr. 2024 Apr 2;12(4):e0188523. doi: 10.1128/spectrum.01885-23. Epub 2024 Mar 15.
7
Whole genome sequencing of Streptococcus pneumoniae: development, evaluation and verification of targets for serogroup and serotype prediction using an automated pipeline.肺炎链球菌全基因组测序:使用自动化流程开发、评估和验证血清群及血清型预测靶点
PeerJ. 2016 Sep 14;4:e2477. doi: 10.7717/peerj.2477. eCollection 2016.
8
Nonpneumococcal Strains Recently Recovered from Carriage Specimens and Expressing Capsular Serotypes Highly Related or Identical to Pneumococcal Serotypes 2, 4, 9A, 13, and 23A.最近从带菌标本中分离出的非肺炎链球菌菌株,其荚膜血清型与肺炎球菌血清型 2、4、9A、13 和 23A 高度相关或相同。
mBio. 2021 May 18;12(3):e01037-21. doi: 10.1128/mBio.01037-21.
9
Genetic relatedness of the Streptococcus pneumoniae capsular biosynthetic loci.肺炎链球菌荚膜生物合成基因座的遗传相关性
J Bacteriol. 2007 Nov;189(21):7841-55. doi: 10.1128/JB.00836-07. Epub 2007 Aug 31.
10
Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene.发现肺炎链球菌血清型 33F 荚膜多糖基因座缺失 wcjE 并含有 wcyO 假基因。
PLoS One. 2018 Nov 5;13(11):e0206622. doi: 10.1371/journal.pone.0206622. eCollection 2018.

引用本文的文献

1
Evolving genomic landscape of pediatric pneumococcus in two Canadian urban centers following conjugate vaccination.在加拿大两个城市中心实施结合疫苗接种后,儿童肺炎球菌的基因组格局变化
Front Microbiol. 2025 Aug 18;16:1642658. doi: 10.3389/fmicb.2025.1642658. eCollection 2025.
2
Genomic analysis and pneumococcal population dynamics across PCV implementation in South Korea, 1997-2023.1997 - 2023年韩国肺炎球菌结合疫苗实施期间的基因组分析与肺炎球菌种群动态
Microb Genom. 2025 Jul;11(7). doi: 10.1099/mgen.0.001433.
3
Prophylactic vaccination strategies for adult patients with diabetes: a narrative review of safety profiles and clinical effectiveness.

本文引用的文献

1
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom.肺炎球菌疾病风险增加的成年人接种肺炎球菌疫苗的证据综述:英国的风险组定义及疫苗接种覆盖率优化
Expert Rev Vaccines. 2023 Jan-Dec;22(1):785-800. doi: 10.1080/14760584.2023.2256394. Epub 2023 Sep 11.
2
Serotype replacement and an increase in non-encapsulated isolates among community-acquired infections of during post-vaccine era in Japan.日本疫苗接种后时代社区获得性感染中血清型替换及非包膜分离株增加。
IJID Reg. 2023 Jul 15;8:105-110. doi: 10.1016/j.ijregi.2023.07.002. eCollection 2023 Sep.
3
成年糖尿病患者的预防性疫苗接种策略:安全性和临床有效性的叙述性综述
Clin Exp Vaccine Res. 2025 Apr;14(2):101-115. doi: 10.7774/cevr.2025.14.e11. Epub 2025 Mar 18.
4
Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development.交叉反应性和交叉保护性对肺炎球菌疫苗研发的影响
Vaccines (Basel). 2024 Aug 28;12(9):974. doi: 10.3390/vaccines12090974.
5
Prevalence of Respiratory Pathogens in Nasopharyngeal Swabs of Febrile Patients with or without Respiratory Symptoms in the Niakhar Area of Rural Senegal.塞内加尔农村尼亚喀尔地区有或无呼吸道症状的发热患者鼻咽拭子中呼吸道病原体的流行情况
Pathogens. 2024 Aug 2;13(8):655. doi: 10.3390/pathogens13080655.
Pneumococcal Serotype Evolution and Burden in European Adults in the Last Decade: A Systematic Review.
过去十年欧洲成年人肺炎球菌血清型演变与疾病负担:一项系统评价
Microorganisms. 2023 May 24;11(6):1376. doi: 10.3390/microorganisms11061376.
4
Risk of Pneumococcal Disease in US Adults by Age and Risk Profile.按年龄和风险特征划分的美国成年人肺炎球菌疾病风险
Open Forum Infect Dis. 2023 Apr 12;10(5):ofad192. doi: 10.1093/ofid/ofad192. eCollection 2023 May.
5
The dynamic change of serotype distribution and antimicrobial resistance of pneumococcal isolates since PCV13 administration and COVID-19 control in Urumqi, China.自中国乌鲁木齐市实施 PCV13 疫苗接种和 COVID-19 防控以来,肺炎链球菌分离株血清型分布和抗菌药物耐药性的动态变化。
Front Cell Infect Microbiol. 2023 Jan 31;13:1110652. doi: 10.3389/fcimb.2023.1110652. eCollection 2023.
6
PneumoKITy: A fast, flexible, specific, and sensitive tool for serotype screening and mixed serotype detection from genome sequence data.PneumoKITy:一种快速、灵活、特异且敏感的工具,可用于从基因组序列数据中进行血清型筛选和混合血清型检测。
Microb Genom. 2022 Dec;8(12). doi: 10.1099/mgen.0.000904.
7
Pneumococcal capsule expression is controlled through a conserved, distal cis-regulatory element during infection.肺炎球菌荚膜表达受感染过程中保守的、远端顺式调控元件的控制。
PLoS Pathog. 2023 Jan 31;19(1):e1011035. doi: 10.1371/journal.ppat.1011035. eCollection 2023 Jan.
8
Post-vaccine epidemiology of serotype 3 pneumococci identifies transformation inhibition through prophage-driven alteration of a non-coding RNA.疫苗接种后 3 型肺炎球菌的流行病学研究表明,通过噬菌体驱动的非编码 RNA 改变来抑制转化。
Genome Med. 2022 Dec 20;14(1):144. doi: 10.1186/s13073-022-01147-2.
9
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study.948263 名≥65 岁人群中 23 价肺炎球菌多糖疫苗对侵袭性肺炎球菌病的有效性:一项丹麦队列研究。
Eur J Clin Microbiol Infect Dis. 2022 Dec;41(12):1473-1477. doi: 10.1007/s10096-022-04513-5. Epub 2022 Oct 25.
10
The remarkable history of pneumococcal vaccination: an ongoing challenge.肺炎球菌疫苗的非凡历史:一项持续的挑战。
Pneumonia (Nathan). 2022 Sep 25;14(1):5. doi: 10.1186/s41479-022-00097-y.